TP53 and Hyperglycemia: In wild-type p53 mice, pancreatic MDMX deficiency did not affect survival to adulthood; however, it significantly inhibited the proliferation of pancreatic endocrine cells and failed to prevent hyperglycemia, ultimately leading to severe diabetic nephropathy and premature death.